West Pharmaceutical Services | WST - Ebitda

Stock Price
230.95
Daily Change
-6.55 -2.76%
Monthly
-17.23%
Yearly
-30.24%
Q1 Forecast
224.00

West Pharmaceutical Services reported $213.1M in EBITDA for its fiscal quarter ending in September of 2025.





Ebitda Change Date
Align Technology USD 203.61M 66M Jun/2025
Avanos Medical USD -63.9M 85.5M Jun/2025
Baxter International USD 462M 137M Jun/2025
Becton, Dickinson and Co. USD 2.15B 674M Sep/2025
Charles River Laboratories USD 282.89M 64.81M Sep/2025
Cooper Companies USD 336.6M 14.8M Sep/2025
Dentsply International USD 167M 30M Sep/2025
Haemonetics USD 115.53M 9.22M Sep/2025
ICU Medical USD 100.31M 36.51M Jun/2025
Insulet USD 160M 2.5M Sep/2025
Integra LifeSciences USD 78.45M 550.67M Sep/2025
IQVIA Holdings USD 949M 39M Sep/2025
J&J USD 9.52B 389M Sep/2025
Medtronic USD 2.44B 139M Sep/2025
Merit Medical Systems USD 83.96M 10.65M Jun/2025
Neogen USD 48.75M 13.28M Sep/2025
Quidel USD 177.1M 70.3M Sep/2025
Repligen USD 35.93M 3.75M Sep/2025
Solventum Corp USD 475M 176M Sep/2025
STAAR Surgical USD 34.62M 49.56M Sep/2025
Terumo JPY 66.76B 10.31B Sep/2025
West Pharmaceutical Services USD 213.1M 14.6M Sep/2025